期刊論文| 1. | Jack, C. R. Jr.、Knopman, D. S.、Jagust, W. J.、Shaw, L. M.、Aisen, P. S.、Weiner, M. W.、Trojanowski, J. Q.(2010)。Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade。The Lancet Neurology，9(1)，119-139。   |
| 2. | Shen, W. W.(2018)。Anticraving therapy for alcohol use disorder: a clinical review。Neuropsychopharmacology Reports，38，105-116。 |
| 3. | 新福尚隆(20120600)。What Is Happening in the Mental Health System in Japan: Some Observations。Taiwanese Journal of Psychiatry，26(2)，70-76+144。 |
| 4. | 武田雅俊、沈武典(20150600)。The Hypothesis of Cognitive Reserve。Taiwanese Journal of Psychiatry，29(2)，70-79+a6。 |
| 5. | Arai, H.、Ouchi, Y.、Toba, K.(2015)。Japan as the front-runner of superaged societies: perspectives from medicine and medical care in Japan。Geriatr Gerontol Int，15，673-687。 |
| 6. | Suzuki, J.(2005)。Trends in change of names for mental diseases in Japan。Seishin Shinkeigaku Zasshi，107。 |
| 7. | Selkoe, D. J.、Ihara, Y.、Salazar, F. J.(1982)。Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea。Science，215，1243-1245。 |
| 8. | Takeda, M.、Tada, K.、Nishimura, T.(1989)。Alteration of cytoskeletal proteins in Alzheimer's disease brain。JANO，3，323-331。 |
| 9. | Tanaka, J.、Murakoshi, K.、Takeda, M.(1988)。A high level of anti-GFAP autoantibody in the serum of patients with Alzheimer's disease。Biomed Res，9，209-216。 |
| 10. | Nukina, N.、Ihara, Y.(1986)。One of the antigenic determinants of paired helical filaments is related to tau protein。J Biochem，99，1541-1544。 |
| 11. | Grundke-Iqbal, I.、Iqbal, K.、Quinlan, M.(1986)。Microtubule-associated protein tau: a component of Alzheimer paired helical filaments。J Biol Chem，261，6084-6089。 |
| 12. | Ihara, Y.、Nukina, N.、Miura, R.(1986)。Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease。J Biochem，99，1807-1810。 |
| 13. | Cooper, R. E.、Tye, C.、Kuntsi, J.(2015)。Omega-3 polyunsaturated fatty acid supplementation and cognition: a systematic review and meta-analysis。J Psychopharmacol，29，753-763。 |
| 14. | Forbes, S. C.、Holroyd-Leduc, J. M.、Poulin, M. J.(2015)。Effect of nutrients, dietary supplements and vitamins on cognition: a systematic review and meta-analysis of randomized controlled trials。Can Geriatr J，18，231-245。 |
| 15. | Geng, J.、Dong, J.、Ni, H.(2010)。Ginseng for cognition。Cochrane Database Syst Rev，12。 |
| 16. | Laws, K. R.、Sweetnam, H.、Kondel, T. K.(2012)。Is ginkgo biloba a cognitive enhancer in healthy individuals? a meta-analysis。Hum Psychopharmacol，27，527-533。 |
| 17. | Fond, G.、Micoulaud-Franchi, J. A.、Brunel, L.(2015)。Innovative mechanisms of action for pharmaceutical cognitive enhancement: a systematic review。Psychiatry Res，229，12-20。 |
| 18. | Giurgea, C.(1972)。Vers une pharmacologie de l'active integrative du cerveau: Tentative du concept nootrope en psychopharmacologie。Actual Pharmacol，25，115-156。 |
| 19. | Hu, Ming-chuan、Huang, Mu-shiang、Wang, Carol Sheei-meei(20200900)。Possible Piracetam-induced Raynaud's Phenomenon in a Male Patient。Taiwanese Journal of Psychiatry，34(3)，138-140。 |
| 20. | Gualtieri, F.、Manetti, D.、Romanelli, M. N.(2002)。Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs。Curr Pharm，2，125-138。 |
| 21. | Sugaya, N.、Ikeda, K.(2011)。Roles of GIRK channels in the reward system。Jpn J Biol Psychiatry，22，263-267。 |
| 22. | Sugaya, N.、Ogai, Y.、Aikawa, Y.(2018)。A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependence。Neuropsychopharmacol Rep，38。 |
| 23. | Whitehouse, P. J.、Price, D. L.、Struble, R. G.(1982)。Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain。Science，215，1237-1239。 |
| 24. | Ogane, N.、Giacobini, E.、Struble, R.(1992)。Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain。Brain Res，589，307-312。 |
| 25. | Schegg, K. M.、Nielsen, S.、Zweig, R. M.(1989)。Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain。Prog Clin Biol Res，317，437-452。 |
| 26. | Kang, J.、Lemaire, H. G.、Unterbeck, A.(1987)。The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor。Nature，325，733-736。 |
| 27. | Wilcock, G. K.、Black, S. E.、Hendrix, S. B.(2008)。Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial。Lancet Neurol，7，483-493。 |
| 28. | Tagami, S.、Takeda, M.、Okochi, M.(2020)。Clinical trials for Alzheimer disease and perspectives。Cognition and Rehabilitation，1(1)，12-19。 |
| 29. | Schenk, D.、Barbour, R.、Dunn, W.(1999)。Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse。Nature，400，173-177。 |
| 30. | Janus, C.、Pearson, J.、McLaurin, J.(2000)。A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease。Nature，408，979-982。 |
| 31. | Bard, F.、Cannon, C.、Barbour, R.(2000)。Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease。Nat Med，6，916-919。 |
| 32. | Hock, C.、Konietzko, U.、Papassotiropoulos, A.(2002)。Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease。Nat Med，8，1270-1275。 |
| 33. | Hock, C.、Konietzko, U.、Streffer, J. R.(2003)。Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease。Neuron，38，547-554。 |
| 34. | Orgogozo, J. M.、Gilman, S.、Dartigues, J. F.(2003)。Subacute meningoencephalitis in subset of patients with AD after Aβimmunization。Neurology，61，46-54。 |
| 35. | Doody, R. S.、Gavrilova, S. I.、Sano, M.(2008)。Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study。Lancet，372，207-215。 |
| 36. | Gompertz, Benjamin(1825)。On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies。Philosophical Transactions of the Royal Society of London，115，513-583。 |